When Great Powers Talk, Who Speaks for Asia 
About the China Capital investigation 
Frequently asked questions about the China Capital investigation 
A volunteer was injected on Friday with the first dose of a rapidly developed vaccine targeting the Bundibugyo strain of Ebola driving a deadly outbreak in the Democratic Republic of Congo (DRC), Oxford University said.
More than 1,000 people have been killed in the DRC and Uganda since the outbreak emerged in May, according to the World Health Organization.
Researchers and health organisations have since been racing to get a vaccine or treatment for the relatively rare strain to the clinical trial stage where it is tested on humans.
Earlier this month, a team at Oxford University in the UK announced it was launching the first trial for its ChAdOx1 BDBV vaccine, which uses the same technology as AstraZeneca’s Covid-19 vaccine.
The first dose was administered to a 37-year-old volunteer named Ed Hunt in Oxford on Friday, a university spokesman said.
“We’ve taken this vaccine candidate from concept to clinic in just eight weeks,” David Pulido-Gomez of Oxford’s Pandemic Sciences Institute said in a statement.
“Reaching this milestone in such a short time frame reflects an extraordinary collaborative effort,” he added.
Don't Miss:
-
China urges ‘constructive dialogue’ with EU in high-level call with France
-
Hong Kong airport builds third runway with strategy to help marine environment thrive
-
Cambodia, Thailand take US$300 billion seabed dispute to UN
-
Hong Kong visitor arrivals hit post-pandemic monthly high in August
-
Indonesian finance minister found out about his firing in mid-meeting phone call